Incyte

photo of a pair of hands that show the skin condition vitiligo
Biotech

Incyte’s vitiligo bet scores ph. 3 wins but can’t shake off Rinvoq

Incyte’s povorcitinib has scored a pair of phase 3 wins for a skin condition, although analysts noted the prospect didn’t quite live up to Rinvoq.
James Waldron Apr 28, 2026 9:52am
Parachute over ocean

Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders

Mar 27, 2026 11:05am
Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm
pipeline valve pipe flow water tap

Prelude loses CMO, pauses SMARCA2 degraders, scores Incyte cash

Nov 4, 2025 9:40am
Group of scientist or doctors and nurses wearing blue protective gloves putting their hands together

Enable Injections, Incyte ink drug delivery collab

Oct 29, 2025 10:15am
pipeline pipes RD research

Incyte scraps BET inhibitor and anti-CD122 drug

Oct 28, 2025 9:05am